RxDoctor Payments Data

Reetu Syal, MD

Obstetrics & Gynecology · Maplewood, MNNPI 1720008204

Payments from drug & device makers

$331in general payments, 2019–2025

Across 22 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exeltis, USA Inc.$65
  • Monaghan Medical Corporation$32
  • Johnson & Johnson$28
  • AbbVie$25
  • Therapeuticsmd, Inc.$24
  • Northgate Technologies, Inc.$24
  • plus $134 from 9 others

What the payments were for

  • Food & beverage$331100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exeltis, USA Inc.5$65
Monaghan Medical Corporation1$32
Johnson & Johnson1$28
AbbVie2$25
Therapeuticsmd, Inc.2$24
Northgate Technologies, Inc.1$24
Daiichi Sankyo Inc.1$20
Axonics, Inc.1$20
Medtronic1$19
Bayer1$17
Roche Diagnostics Corporation1$14
Coopersurgical, Inc.1$14
Pfizer1$14
Sage Therapeutics, LLC1$14
Unified Women's Healthcare, LP2$0

How this compares

$331 in reported general payments places this provider in the 65th percentile of 615 obstetrics & gynecology providers in Minnesota.

See all obstetrics & gynecology providers in Minnesota

Medicare billing

Part B allowed, 2024
$7,770
Medicare patients
38
Services billed
90

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated26$8,121
Estradiol47$3,293
ProgesteroneProgesterone, Micronized12$535
Clobetasol Propionate17$391
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$370

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$14$8,12126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 615 obstetrics & gynecology providers in Minnesota.

Other obstetrics & gynecology in Maplewood

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →